Should I Invest In British American Tobacco Plc Now?

Can British American Tobacco plc (LON: BATS) still deliver a decent investment return?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Cigarette manufacturer British American Tobacco (LSE: BATS) (NYSE: BTI.NY) enjoys a 42% equity position in its tobacco peer Reynolds American. That connection comes under the spotlight this week as Reynold American confirms its acquisition of another industry player Lorilland, which could involve some of both companies’ assets going to yet another tobacco firm, London-listed Imperial Tobacco.

Pulling together

British American Tobacco makes its position clear: the firm intends to support the transaction by subscribing for additional shares in Reynolds American, with the aim of maintaining its 42% equity position.

Such consolidation and close working seems vital in what appears to be an industry in structural decline. If one firm is a better fit for a particular market, why should tobacco sellers fight it out? Far better to co-operate and combine for mutual benefit, just as this potential deal suggests is happening in the industry.

Declining sales volumes

Last year British American Tobacco’s sales volumes declined around 2.7% even though the firm reckons it’s winning market share. That’s strong evidence of a slipping industry; yet, overall, BATS trading delivers a flat-looking performance on revenue and cash flow:

Year to December

2009

2010

2011

2012

2013

Revenue (£m)

14,208

14,883

15,399

15,190

15,260

Net cash from operations (£m)

3,878

4,490

4,566

4,427

4,436

Adjusted earnings per share

153.8p

176.7p

195.8p

208.6p

217.4p

Dividend per share

99.5p

114.2p

126.5p

134.9p

142.4p

A steady stream of repeat business from addicted smokers delivers cash flow, which the firm uses to buy back its own shares to drive up earnings-per-share and dividend-per-share figures.

So far, BATS’ market-share gains are keeping cash flow steady. However, it won’t take much for industry volume declines to tip the balance over market-share gains, which could lead to cash flow decline. That could threaten dividend progression.

So potential industry supporting deals like this one should help tobacco producers such as BATS to keep the cash taps open by extracting every last puff of revenue from smokers as efficiently as possible.

Valuation

At a share price of 3586p, BATS shares change hands on a forward P/E multiple of just under 16 for 2015. City analysts reckon the firm should see 8% growth in its earnings that year and the dividend will likely yield upwards of 4.4%. Forward earnings will cover the payout about one-and-a-half times based on current predictions.

There’s no doubt that British American Tobacco is operating as something of a cash-cow, managing to drive the dividend payment up year after year. However, I can’t bring myself to invest in a firm with poor revenue prospects no matter how well it manages its cash supply for investor income.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin does not own shares in British American Tobacco.

More on Investing Articles

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

This 1 simple investing move accelerated Warren Buffett’s wealth creation

Warren Buffett has used this easy to understand investing technique for decades -- and it has made him billions. Our…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

Down 6% in 2 weeks, the Lloyds share price is in reverse

After hitting a one-year high on 8 April, the Lloyds share price has suddenly reversed course. But as a long-term…

Read more »

Investing Articles

£3,000 in savings? Here’s how I’d use that to start earning a monthly passive income

Our writer digs into the details of how spending a few thousand pounds on dividend shares now could help him…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BP share price in the next three years

I can understand why the BP share price is low, as oil's increasingly seen as evil. But BP's a cash…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »